Stephen Whitehead

Type: Person
Name: Stephen Whitehead
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Seven pharma companies offer up compounds to UK researchers

Business Secretary Vince Cable has announced that UK researchers will be granted access to a ‘virtual library’ of deprioritised pharmaceutical compounds through a new partnership between the Medical Research Council (MRC) and seven global drug compan ... [Published European Pharmaceutical Manufacturer - Jul 30 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

MRC Links With 7 Big Pharma Firms For Drug Research

By The Medical Research Council (MRC) has partnered with seven global big pharma firms to search new uses for deprioritized pharmaceutical compounds. These are AstraZeneca, Eli Lilly & Co., GlaxoSmithKline, Janssen R&D, Pfizer, Takeda, and UCB.British ... [Published Pharmaceutical Online - Jul 26 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 2 reports

Seven pharma companies offer deprioritized compounds for re-purposing

U.K. researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds through a new partnership between the Medical Research Council (MRC) and seven global drug companies.AstraZeneca , GlaxoSmithKline , Janssen R&D , ... [Published Center Watch - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

ABPI establishes Inward Investor Group

The Association of the British Pharmaceutical Industry (ABPI) has established a new Inward Investor Group to demonstrate the importance of inward investment to the U.K. and the global mobility of such investment. The group also will work toward cultivating ... [Published Center Watch - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 4 reports

Researchers Granted Access to Abandoned Compounds

The U.K.'s Medical Research Council (MRC) has inked a partnership with seven pharmaceutical firms—AstraZeneca, GlaxoSmithKline, Janssen Research & Development, Eli Lilly , Pfizer , Takeda , and UCB—giving U.K. researchers access to a virtual library of ... [Published Genetic Engineering News - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Pharma bands together to attract UK investment

Industry leaders are banding together to help cultivate a more attractive environment in the UK for pharmaceutical companies to invest in.The Association of the British Pharmaceutical Industry has established a new Inward Investor Group currently including ... [Published Pharma Times - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Become customer-centric by knowing who your customer is

There are different strategies for becoming customer-centric depending on whom your product benefits most. Although sometimes the interests of different stakeholders can be aligned, market prioritization remains important.In the discovery and development ... [Published eyeforpharma.com - Jul 21 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

Science minister leaves post

Science and engineering bodies today hailed the work of departing Science and Universities minister David Willetts, who was removedfrom his post by Prime Minister David Cameron in his cabinet reshuffle.Willetts led a number of initiatives to boost skills ... [Published Laboratorytalk - Jul 15 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

UK cancer patients face increasing coverage restriction, US report shows

New US research released yesterday quantifies the extent to which centralized value assessments by the UK’s health care cost watchdog National Institute for Health and Care Excellence (NICE) lead to coverage denials and patient access restrictions to ... [Published Pharma Letter - Jul 11 2014]
First reported Jul 10 2014 - Updated Jul 11 2014 - 1 reports

'Shocking and unacceptable' rise in UK animal testing

A small but significant increase in the number of animal experiments in Great Britain in 2013 has caused dismay among charities who have accused the UK government of breaking its promises.Home Office figures have been released which reveal the number ... [Published Pharma Times - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Govt invests £52 million to address science skills gap

Contractors are being used to plug the skills gap across multiple industries, but it is perhaps science-related subjects where demand is at its highest level. This has been primarily attributed to the fact that not enough young talent is choosing STEM ... [Published Brookson - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Government invests £52m in UK science

The government announced today that it is granting £52m to the UK science sectors in order to boost skills and trading.The funding has been given to the Science Industrial Partnership, which is led by GlaxoSmithKline and aims to develop vocational training ... [Published City A.M. - Jul 08 2014]

More Content

All (31) | News (30) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Seven pharma companies offer up compounds to UK... [Published European Pharmaceutical Manufacturer - Jul 30 2014]
MRC Links With 7 Big Pharma Firms For Drug Rese... [Published Pharmaceutical Online - Jul 26 2014]
ABPI establishes Inward Investor Group [Published Center Watch - Jul 24 2014]
Seven pharma companies offer deprioritized comp... [Published Center Watch - Jul 24 2014]
Pharma firms offer ‘deprioritised’ compounds [Published TCE Today - Jul 24 2014]
Seven pharma companies offer up compounds to UK... [Published AstraZeneca - Jul 22 2014]
Researchers Granted Access to Abandoned Compounds [Published Genetic Engineering News - Jul 22 2014]
Pharma bands together to attract UK investment [Published Pharma Times - Jul 22 2014]
Pharma firms to offer up compounds [Published Laboratorytalk - Jul 22 2014]
Pharma firms open up drug libraries to UK resea... [Published PMLive - Jul 22 2014]
Pharma pact with MRC to 'repurpose' stalled com... [Published Pharma Times - Jul 22 2014]
Become customer-centric by knowing who your cus... [Published eyeforpharma.com - Jul 21 2014]
Science minister leaves post [Published Laboratorytalk - Jul 15 2014]
UK cancer patients face increasing coverage res... [Published Pharma Letter - Jul 11 2014]
'Shocking and unacceptable' rise in UK animal t... [Published Pharma Times - Jul 10 2014]
Govt invests £52 million to address science ski... [Published Brookson - Jul 09 2014]
Government invests £52m in UK science [Published City A.M. - Jul 08 2014]
Press release: £52 million boost for skills and... [Published Government UK - Jul 08 2014]
UK pharma refunds £74m to cover first three-mon... [Published Binleys - Jul 01 2014]
ABPI welcomes first payments to UK’s Pharmaceut... [Published Pharma Letter - Jun 30 2014]
Pharma makes first payment to underwrite UK dru... [Published Pharma Times - Jun 30 2014]
‘Dad will be looking down from heaven with a bi... [Published Fleetwood WeeklyNews - Jun 27 2014]
‘Dad will be looking down from heaven with a bi... [Published NewsRT.co.uk - Jun 27 2014]
Jonathan Emms Takes up Appointment as ABPI Pres... [Published Labmate Online - Jun 26 2014]
Burton Financial Partners' Continues Expansion ... [Published I-Newswire - Jun 25 2014]
Doctors advised against aspirin for patients wi... [Published Guardian.co.uk - Jun 18 2014]
ABPI welcomes Department of Health’s decision t... [Published PharmiWeb - Apr 15 2014]
GSK Poland - Shelley Jofre writes in the BMJ [Published PharmaGossip - Apr 14 2014]
Fish rot from the head [Published open Democracy News Analysis - - Mar 20 2014]
ABPI comments on the Prime Minister's speech to... [Published PharmiWeb - Dec 11 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
GSK Poland - Shelley Jofre writes in the BMJ [Published PharmaGossip - Apr 14 2014]
Shelley Jofre, BBC Panorama correspondent shelley.jofre@bbc.co.uk The company may have broken US and UK laws on bribery, says  Shelley Jofre GlaxoSmithKline (GSK) recently announced that by 2016 it will end direct payments to doctors for promotional talks ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.